Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 2
Submit an article Journal homepage
2
Views
0
CrossRef citations to date
0
Altmetric
Articles

Worsening heart failure following cardiac resynchronization therapy: An electrocardiographic diagnosis

Marc VanderheydenCardiovascular Centre, Onze-Lieve-Vrouwziekenhuis, Aalst, BelgiumCorrespondence[email protected]
,
Tom De PotterCardiovascular Centre, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
&
Marc GoethalsCardiovascular Centre, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium
Pages 211-213 | Received 28 Sep 2005, Accepted 24 Oct 2006, Published online: 23 May 2017

References

  • Barold SS, Herweg B, Giudici M. Electrocardiographic follow-up of biventricular pacemakers. Ann Noninvasive Electrocardiol 2005; 10: 231–55.
  • Ammann P, Sticherling C, Kalusche D, Eckstein J, Bernheim A, Schaer B, Osswald S. An electrocardiogram-based algorithm to detect loss of left ventricular capture during cardiac resynchronization therapy. Ann Intern Med 2005; 142: 968–73.
  • Ricci R, Pignalberi C, Ansalone G, Jannone E, Vaccaro MV, Denaro A, Cavaglia S, Santini M. Early and late QRS morphology and width in biventricular pacing: relationship to lead site and electrical remodeling. J Interv Card Electro-physiol 2002; 6: 279–85.
  • Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation 2003; 108: 10/1/1 8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.